Shenqi Fuzheng Injection Alleviates the Transient Worsening Caused by Steroids Pulse Therapy in Treating Myasthenia Gravis

Table 2

Clinical absolute and relative scores for patients with MG.

Ptosis (upper eyelid position)	Upper eyelid fatigue test (sec)	Eyeball horizontal movement (white of the eye, mm)	Upper limb fatigue test—arm outstretched (sec)	Lower limb fatigue test—knee and hip flexion at 90° (sec)	Facial muscles	Chewing and swallowing	Respiratory muscle
0 = normal	0 = >60	0 = ≤2, no diplopia	0 = >120	0 = >120	0 = normal with eyelashes all covered by eyelids	0 = normal function	0 = normal function
1 = 10–2 o’clock	1 = 31–60	1 = 3-4, with diplopia	1 = 61–120	1 = 61–120	1 = slightly reduced eye closure strength, eyelashes incompletely covered	2 = fatigue with solid food, prolonged food intake but normal food amount	2 = shortness of breath with movement or exertion
2 = 9–3 o’clock	2 = 16–30	2 = 5–8, with diplopia	2 = 31–60	2 = 31–60	2 = reduced eye closure strength, eyelashes all exposed outside	4 = fatigue with solid food, prolonged and decreased food intake	4 = shortness of breath with walking on a leveled area
3 = 8–4 o’clock	3 = 6–15	3 = 9–12, with diplopia	3 = 11–30	3 = 11–30	3 = can neither close eyelids nor puff up cheeks	6 = semifluid food only	6 = shortness of breath with sitting still
4 = 7–5 o’clock	4 = ≤5	4 = >12, with diplopia	4 = 0–10	4 = 0–10	4 = cannot pout with a masklike face	8 = nasal feeding only	8 = mechanical ventilation

Clinical relative score (CRS) = (pretreatment absolute score − posttreatment absolute score)/pretreatment absolute score.
Effect score: (1) complete remission if CRS ≥ 95%, (2) basic remission if CRS 80–95%, (3) marked improvement if CRS 50–80%, (4) improvement if CRS 25–50%, and (5) ineffectiveness if CRS < 25%.